Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodefici...

由 Sidhu, Jagdev, Rojavin, Mikhail, Pfister, Marc, Edelman, Jonathan
發表在 Biol Ther (2014)

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

由 Bygum, Anette, Martinez-Saguer, Inmaculada, Bas, Murat, Rosch, Jeffrey, Edelman, Jonathan, Rojavin, Mikhail, Williams-Herman, Debora
發表在 Drugs Aging (2016)

Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hour...

由 Rhame, Frank S., Rawlins, Sandy L., Petruschke, Richard A., Erb, Tara A., Winchell, Gregory A., Wilson, Helene M., Edelman, Jonathan M., Abramson, Murray A.
出版 2004

The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials

由 Ma, Shuren, Lin, Yong Y., Cantor, Jerome O., Chapman, Kenneth R., Sandhaus, Robert A., Fries, Michael, Edelman, Jonathan M., McElvaney, Gerard, Turino, Gerard M.
發表在 Chronic Obstr Pulm Dis (2016)

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

由 Merkies, Ingemar S. J., Lawo, John‐Philip, Edelman, Jonathan M., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Léger, Jean‐Marc
發表在 J Peripher Nerv Syst (2017)

Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency

由 Tortorici, Michael A., Rogers, James A., Vit, Oliver, Bexon, Martin, Sandhaus, Robert A., Burdon, Jonathan, Chorostowska‐Wynimko, Joanna, Thompson, Philip, Stocks, James, McElvaney, Noel G., Chapman, Kenneth R., Edelman, Jonathan M.
發表在 Br J Clin Pharmacol (2017)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

由 Craig, Timothy, Shapiro, Ralph, Vegh, Arthur, Baker, James W., Bernstein, Jonathan A., Busse, Paula, Magerl, Markus, Martinez-Saguer, Inmaculada, Riedl, Marc A., Lumry, William, Williams-Herman, Debora, Edelman, Jonathan, Feuersenger, Henrike, Machnig, Thomas, Rojavin, Mikhail
發表在 Allergy Rhinol (Providence) (2017)

Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases

由 Wanner, Adam, Groft, Stephen C., Teagarden, J. Russell, Krischer, Jeffrey, Davis, Barry R., Coffey, Christopher S., Hickam, David H., Teckman, Jeffrey, Nelson, David R., McCaleb, Michael L., Loomba, Rohit, Strange, Charlie, Sandhaus, Robert A., Brantly, Mark, Edelman, Jonathan M., Farrugia, Albert
發表在 Chronic Obstr Pulm Dis (2015)